Characterization of porcine tumor necrosis factor receptor 2: Implications for xenotransplantation

被引:5
|
作者
Costa, C.
Casinghino, S. R.
Fodor, W. L.
机构
[1] Hosp Llobregat, Hosp Duran & Reynals, Inst DInvest Biomed & Bellvitge IDIBELL, Barcelona 08907, Spain
[2] Alexion Pharmaceut Inc, Dept Mol Sci, Cheshire, CT USA
[3] Hosp Llobregat, Inst Invest Biomed & Bellvitge, Barcelona, Spain
[4] Univ Connecticut, Dept Mol & Cellular Biol, CT Ctr Regenerat Biol, Storrs, CT USA
关键词
D O I
10.1016/j.transproceed.2007.07.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical solid organ xenotransplantation is precluded by the strong immune response that results in rejection of pig xenografts in primate models. Innate immunity seems to play a major role in this process. In particular, tumor necrosis factor (TNF), produced by natural killer cells and macrophages, contributes to xenograft rejection by promoting endothelial cell activation and the recruitment of inflammatory cells. To further elucidate its molecular mechanism, we cloned the full-length cDNA of porcine TNF-Receptor 2 (pTNFR2, p75) by reverse transcriptase polymerase chain reaction (PCR) of total RNA isolated from porcine peripheral blood mononuclear cells. To this end, we used degenerate primers based on the sequences of the mouse, rat, and human homologues. Two PCR fragments were obtained that contained the pTNFR2 sequence, but differed in size. The shorter clones lacked the sequence corresponding to exon 4 by homology but identical for the rest, suggesting there is an alternative spliced mRNA variant of the porcine receptor. The predicted protein sequence (461 amino acids, containing exon 4) exhibited 72.5% identity to the human TNFR2 and 58.7% to the mouse molecule. By predicted protein sequence analysis, we determined that it comprised the four TNFR cysteine-rich repeats conserved between species. However, the molecule missing exon 4 lacks one cysteine-rich repeat. To assess function, we produced two recombinant proteins containing the extracellular domain of each pTNFR2 variant fused to the Fc portion of human IgG1. Next, we examined their ability to inhibit human TNF-mediated activation of porcine aortic endothelial cells. The addition of the whole pTNFR2 fusion protein to the TNF treatment blocked the up-regulation of activation markers. However, the fusion protein lacking exon 4 failed to effectively counteract TNF effects. These two pTNFR2 isoforms may play differential roles in the process of xenograft rejection.
引用
收藏
页码:2443 / 2446
页数:4
相关论文
共 50 条
  • [31] Roles of tumor necrosis factor receptor 1 and receptor 2 in insulin receptor signaling
    Sethi, JK
    Xu, HY
    Hotamisligil, GS
    DIABETES, 1999, 48 : A219 - A219
  • [32] Molecular characterization and functional analysis of tumor necrosis factor receptor-associated factor 2/7 and tumor necrosis factor receptor 1-associated death domain protein from Larimichthys crocea
    Hu, SiLing
    Wang, LuPing
    Xie, Xiaoze
    Yang, Xiao
    Cai, Linwei
    Zhu, Aiyi
    FISH & SHELLFISH IMMUNOLOGY, 2020, 103 : 385 - 402
  • [33] Necrosis factor is trafficked to mitochondria where immunoreactive tumor necrosis factor receptor 2 is localized.
    Bradley, JR
    Bright, NA
    Faraco, P
    Jones, S
    Ledgerwood, L
    ORahilly, S
    Prins, JB
    Savidge, J
    Smith, K
    Wolfreys, K
    Pober, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2011 - A2011
  • [34] Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity
    Takanori So
    Seung-Woo Lee
    Michael Croft
    International Journal of Hematology, 2006, 83 : 1 - 11
  • [35] Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity
    So, T
    Lee, SW
    Croft, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (01) : 1 - 11
  • [36] Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
    Zaitseva, Olena
    Anany, Mohamed
    Wajant, Harald
    Lang, Isabell
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Behavior of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptor 1/Tumor Necrosis Factor Receptor 2 System in Mononuclear Cells Recovered From Peritoneal Fluid of Women With Endometriosis at Different Stages
    Salmeri, Francesca M.
    Lagana, Antonio S.
    Sofo, Vincenza
    Triolo, Onofrio
    Sturlese, Emanuele
    Retto, Giovanni
    Pizzo, Alfonsa
    D'Ascola, Angela
    Campo, Salvatore
    REPRODUCTIVE SCIENCES, 2015, 22 (02) : 165 - 172
  • [38] Behavior of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptor 1/Tumor Necrosis Factor Receptor 2 System in Mononuclear Cells Recovered From Peritoneal Fluid of Women With Endometriosis at Different Stages
    Francesca M. Salmeri
    Antonio Simone Laganà
    Vincenza Sofo
    Onofrio Triolo
    Emanuele Sturlese
    Giovanni Retto
    Alfonsa Pizzo
    Angela D’Ascola
    Salvatore Campo
    Reproductive Sciences, 2015, 22 : 165 - 172
  • [39] Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2
    Lainez, B
    Fernandez-Real, JM
    Romero, X
    Esplugues, E
    Cañete, JD
    Ricart, W
    Engel, P
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (01) : 169 - 177
  • [40] Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytes
    Lung, HL
    Leung, KN
    Stadlin, A
    Ma, CM
    Tsang, D
    LIFE SCIENCES, 2001, 68 (18) : 2081 - 2091